Tarafenacin D-tartrate

Overview

Tarafenacin (SVT-40776) D-tartrate is an orally active, selective M3 muscarinic receptor ( M3 muscarinic receptor ) antagonist with 203-fold selectivity over the M2 muscarinic receptor. Tarafenacin D-tartrate does not affect atrial contraction, arterial blood pressure or arterial pressure at high doses. Tarafenacin D-tartrate can be used in the research of overactive bladder.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Urologic Disease | Products > Disease Areas > Genitourinary Inflammation | Products > Disease Areas > Cystitis | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > mAChR

Product Information

• Catalog No.: HY-14825A
• CAS No.: 1159101-48-0
• Molecular Formula: C25H26F4N2O8
• Molecular Weight: 558.48
• Purity: 99.75%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (4.48 mM); Clear solution
• Availability: In-stock

Source

Original product source